RDHL - Redhill Biopharma Ltd ADR Options

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: TEVA AMPH VTRS LPCN OMER

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-	Insider Own	11.09%	Shs Outstand	5.19M	Perf Week	6.05%
Market Cap	5.14M	Forward P/E	-	EPS next Y	-	Insider Trans	-96.47%	Shs Float	4.62M	Perf Month	-3.41%
Enterprise Value	2.32M	PEG	-	EPS next Q	-	Inst Own	9.99%	Short Float	0.41%	Perf Quarter	0.00%
Income	-	P/S	-	EPS this Y	-	Inst Trans	1.70%	Short Ratio	0.32	Perf Half Y	-4.81%
Sales	-	P/B	-	EPS next Y	-	ROA	-	Short Interest	0.02M	Perf YTD	-3.88%
Book/sh	-1.93	P/C	1.70	EPS next 5Y	-	ROE	-	52W High	3.31 -70.09%	Perf Year	-46.20%
Cash/sh	0.58	P/FCF	-	EPS past 3/5Y	95.56% 86.32%	ROIC	-	52W Low	0.71 39.42%	Perf 3Y	-98.20%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-83.27% -66.14%	Gross Margin	-	Volatility	8.59% 6.29%	Perf 5Y	-99.99%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	94.66%	Oper. Margin	-	ATR (14)	0.06	Perf 10Y	-99.99%
Dividend Ex-Date	-	Quick Ratio	0.42	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	54.01	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	0.56	EPS Q/Q	102.33%	SMA20	-1.64%	Beta	5.00	Target Price	7.75
Payout	-	Debt/Eq	-	Sales Q/Q	-90.21%	SMA50	9.06%	Rel Volume	4.00	Prev Close	0.98
Employees	13	LT Debt/Eq	-	Earnings	Apr 27 BMO	SMA200	-17.83%	Avg Volume	58.76K	Price	0.99
IPO	Jan 07, 2013	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	45,504	Change	1.04%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)